The benefits of systematic intraoperative sampling during lower limb arthroplasties due to sequelae from prior osteoarticular infections: A retrospective study of 92 cases.


Journal

Orthopaedics & traumatology, surgery & research : OTSR
ISSN: 1877-0568
Titre abrégé: Orthop Traumatol Surg Res
Pays: France
ID NLM: 101494830

Informations de publication

Date de publication:
04 2022
Historique:
received: 16 05 2021
revised: 08 08 2021
accepted: 14 09 2021
pubmed: 22 12 2021
medline: 20 4 2022
entrez: 21 12 2021
Statut: ppublish

Résumé

Osteoarticular infections (OAIs) of native joints lead to cartilage damage which may require subsequent arthroplasty. There is no consensus on systematic intraoperative microbiological sampling when performing an arthroplasty on a native joint with a history of OAI. We carried out a retrospective study to: (1) identify the frequency of the persistence of the microorganism(s) involved during the initial, presumed cured OAI, when performing an arthroplasty for sequelae of osteoarthritis, (2) to find an association between the length of time between the OAI and arthroplasty, and the recurrence of bacterial infection, (3) to assess the influence of the presence of hardware on the risk of infectious recurrence. Systematic sampling is justified during a subsequent arthroplasty after an OAI, even after a prolonged period. This single-center, retrospective descriptive study included all patients whose indication for arthroplasty resulted from osteoarthritis, osteitis or bacterial osteomyelitis of a native joint, or in the aftermath of an infection post osteosynthesis. All patients were considered to have recovered from the initial infection at the time of the arthroplasty. Between 2008 and 2019, 92 patients were included in the study, with an average age of 56.5years (range: 21-97years). OAI occurred at a mean age of 35years (range: 1-84years). The average time from OAI to implantation was 15years (range: 1-65years). The bacteria most frequently found in the initial OAI was Staphylococcus aureus, involved in 35.8% of cases (n=33/92). The intraoperative samples came back positive in 17% of cases (n=16/92), including 9 positive for the same bacteria as the OAI (56%, n=9/16). For these 16 cases, the time between the OAI and the arthroplasty was 1year for 5 patients, between 1 and 15years for 5 patients and greater than 15years for 6 patients. For 3 positive patients, the information on the initial microorganism was not known and 4 patients were positive for a bacterium different from the initial one. The time from the initial OAI to the arthroplasty was not associated with positive results (p=0.38). There was no significant difference between a positive culture at the time of arthroplasty and the initial type of OAI [native joint versus presence of hardware and/or open fracture (p=0.41)]. The results of this work suggest there is value in microbiological sampling when performing an arthroplasty on a previously infected joint, regardless of the duration of the infection. IV; retrospective study.

Identifiants

pubmed: 34933132
pii: S1877-0568(21)00468-0
doi: 10.1016/j.otsr.2021.103189
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103189

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

Nicolas Mainard (N)

Département de chirurgie pédiatrique, hôpital Jeanne-de-Flandre, CHU Lille, avenue Eugène-Avinée, 59000 Lille, France; Université de Lille Haut-de-France, 59037 Lille, France; Centre de Référence pour le traitement des Infections Ostéo-Articulaires Complexes (CRIOAC) de Lille-Tourcoing, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France. Electronic address: nicolas.mainard@orange.fr.

Marc Saab (M)

Université de Lille Haut-de-France, 59037 Lille, France; Centre de Référence pour le traitement des Infections Ostéo-Articulaires Complexes (CRIOAC) de Lille-Tourcoing, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France; Département universitaire de chirurgie orthopédique et de traumatologie, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France.

Julien Dartus (J)

Université de Lille Haut-de-France, 59037 Lille, France; Centre de Référence pour le traitement des Infections Ostéo-Articulaires Complexes (CRIOAC) de Lille-Tourcoing, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France; Département universitaire de chirurgie orthopédique et de traumatologie, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France.

Pierre Martinot (P)

Université de Lille Haut-de-France, 59037 Lille, France; Centre de Référence pour le traitement des Infections Ostéo-Articulaires Complexes (CRIOAC) de Lille-Tourcoing, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France; Département universitaire de chirurgie orthopédique et de traumatologie, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France.

Caroline Loiez (C)

Centre de Référence pour le traitement des Infections Ostéo-Articulaires Complexes (CRIOAC) de Lille-Tourcoing, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France; Service de bactériologie-hygiène, institut de microbiologie, centre de biologie pathologie, CHU Lille, boulevard du Pr-Jules-Leclercq, 59000 Lille, France.

Marie Titecat (M)

Université de Lille Haut-de-France, 59037 Lille, France; Centre de Référence pour le traitement des Infections Ostéo-Articulaires Complexes (CRIOAC) de Lille-Tourcoing, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France; Service de bactériologie-hygiène, institut de microbiologie, centre de biologie pathologie, CHU Lille, boulevard du Pr-Jules-Leclercq, 59000 Lille, France.

Henri Dezeque (H)

Centre de Référence pour le traitement des Infections Ostéo-Articulaires Complexes (CRIOAC) de Lille-Tourcoing, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France; Département universitaire de chirurgie orthopédique et de traumatologie, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France.

Sophie Putman (S)

Université de Lille Haut-de-France, 59037 Lille, France; Centre de Référence pour le traitement des Infections Ostéo-Articulaires Complexes (CRIOAC) de Lille-Tourcoing, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France; Département universitaire de chirurgie orthopédique et de traumatologie, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France.

Eric Senneville (E)

Université de Lille Haut-de-France, 59037 Lille, France; Centre de Référence pour le traitement des Infections Ostéo-Articulaires Complexes (CRIOAC) de Lille-Tourcoing, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France; Département universitaire des maladies infectieuses et du voyageur, hôpital Gustave-Dron, 135, rue du Président-Coty, 59200 Tourcoing, France.

Henri Migaud (H)

Université de Lille Haut-de-France, 59037 Lille, France; Centre de Référence pour le traitement des Infections Ostéo-Articulaires Complexes (CRIOAC) de Lille-Tourcoing, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France; Département universitaire de chirurgie orthopédique et de traumatologie, hôpital Salengro, CHU Lille, place de Verdun, 59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH